TYK2-KINASE-INHIBITOREN
European patent · EP3864009 · In force
Register entry
- Publication number
- EP3864009
- Application number
- EP19794095
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 7, 2019
- Published
- Aug 18, 2021
- Granted
- Feb 19, 2025
- Protection ends at the latest
- Oct 6, 2039
- Next annual fee due
- Oct 31, 2026
- IPC classes
- C07D 263/48 (2006.01)A61P 29/00 (2006.01)A61P 37/00 (2006.01)A61K 31/541 (2006.01)
- Priority
- GB 201816369 08.10.2018
- PCT application
- PCT/EP2019/077118 07.10.2019
- PCT publication
- WO2020/074461 16.04.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 31, 2025
Change
Published in Swissreg on 31.12.2025
- Nov 1, 2025
Change
Published in Swissreg on 01.11.2025
- Feb 21, 2025
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 21.02.2025
- Feb 19, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 19.02.2025
Parties
Holder
Inventor
READER, John Charles
Cambridgeshire CB22 3FX, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.